SCHEMBL8795073

SCHEMBL8795073

CC(C)(C)OC(=O)NCCOc1ccc(NS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.64
CA1 P00915 5/20 0.64
CA2 P00918 5/20 0.64
CA9 Q16790 5/20 0.64
MEN1 O00255 1/20 0.55
MAPT P10636 1/20 0.55
KMT2A Q03164 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.53
PKM P14618 2/20 0.53
AR P10275 2/20 0.52
HTT P42858 1/20 0.51
RECQL P46063 1/20 0.50
CACNA1B Q00975 1/20 0.49
LMNA P02545 1/20 0.49
PDK2 Q15119 1/20 0.48
PSEN1 P49768 1/20 0.48
PSEN2 P49810 1/20 0.48
APH1B Q8WW43 1/20 0.48
NCSTN Q92542 1/20 0.48
APH1A Q96BI3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675706 0.83 CA12 (0.67) CA12CA1CA2CA9MAPT
SCHEMBL20946387 0.81 LMNA (0.58) CA12CA1CA2LMNAALDH1A1
SCHEMBL17309069 0.79 CA12 (0.66) CA12CA1CA2CA9MAPT
SCHEMBL7079519 0.79 MEN1 (0.58) MEN1MAPTKMT2ASMN1; SMN2PKM
SCHEMBL13306489 0.79 CA1 (0.66) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL24920672 0.79 CA12 (0.67) CA12CA1CA2CA9MEN1
SCHEMBL21625809 0.79 CA1 (0.76) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL25623328 0.78 CA12 (0.62) CA12CA1CA2CA9MEN1
SCHEMBL7486439 0.77 ITGB3 (0.60) CA12CA1CA2CA9SMN1; SMN2
SCHEMBL4459617 0.77 CA12 (0.65) CA12CA1CA2CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0611003-B1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO INC (US) 1997-06-18 EP disclosed
US-5451677-A Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity MERCK & CO., INC. (US) 1995-09-19 US disclosed
EP-0611003-A1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO. INC. (US) 1994-08-17 EP disclosed